Latest News about MDGL
Recent news which mentions MDGL
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 19, 2022
From Benzinga
Tesla, Amazon, Madrigal Pharma, Pfizer, Synaptogenix: Why These 5 Stocks Are Drawing Investors' Attention Today
December 18, 2022
From Benzinga
2 Healthcare Stocks Poised to Rocket Higher in the 4th Quarter
November 06, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
October 28, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 25, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 17, 2022
From Benzinga
Wall Street Thinks These 2 Nasdaq Stocks Could Go Parabolic Soon
September 15, 2022
From Motley Fool
From Benzinga
Analysts Believe Madrigal's Resmetirom Shows Impressive Overall Profile In Liver Fibrosis
June 27, 2022
Tickers
MDGL
From Benzinga
From Benzinga
Earnings Scheduled For May 9, 2022
May 09, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 03, 2022
From Benzinga
Why Madrigal Pharmaceuticals Stock Briefly Spiked Today
January 31, 2022
Tickers
MDGL
From Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 31, 2022
From Benzinga
3 Biotech Stocks With Major Catalysts in January
January 04, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
October 07, 2021
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
From Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
From Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Monday
August 16, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.